[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.226.244.70. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Original Article
September 2002

Decrease of Specific and Total IgE Levels in Allergic Patients After BCG Vaccination: Preliminary Report

Author Affiliations

From the Dipartimento di Fisiopatologia Clinica, I Clinica Otorinolaringoiatrica, University of Turin, Turin, Italy.

Arch Otolaryngol Head Neck Surg. 2002;128(9):1058-1060. doi:10.1001/archotol.128.9.1058
Abstract

Background  A systemic reaction to mycobacteria biases the balance of T helper cell types 1 and 2 toward T helper cell type 1. BCG vaccination mimics some characteristics of mycobacterial infection. Children who have undergone tuberculin conversion after BCG vaccination seem to be more likely to lose their atopic symptoms. Inhibition of both allergic response and airway hyperreactivity after vaccination for mycobacteria has been observed in animal experiments.

Objective  To evaluate the effects that BCG vaccination has on the serological status of allergic people.

Participants and Methods  This study included 20 volunteers with a history of allergic rhinitis who were required to undergo BCG vaccination by Italian law. Epicutaneous allergy testing with a panel of common seasonal and perennial inhalational allergens and 2 blood withdrawals were performed. The serum total IgE levels and the serum allergen-specific IgE levels of each individual were measured just before BCG vaccination and again 4 months later. Total IgE levels were determined using the paper radioimmunosorbent test, and allergen-specific IgE levels were determined using the radioallergosorbent test.

Results  Total IgE and allergen-specific IgE levels were significantly decreased after BCG vaccination (P = .004 and P<.001, respectively).

Conclusion  BCG, an effective stimulus for cell-mediated immunity, deserves further study to evaluate its ability to modulate the immune response associated with allergic rhinitis.

×